Simplify Logo

Full-Time

Quality Assurance Technician

2nd/3rd shifts

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Compensation Overview

$21 - $29Hourly

Entry

Sacramento, CA, USA

Onsite position at 7910 Metro Air Parkway, Sacramento, CA.

Category
QA & Testing
Quality Assurance
Requirements
  • Ability to wear cleanroom gowning and meet the requirements of the controlled, classified spaces
  • Perform shift work to support 24-hour manufacturing operations
  • Identify and support resolution of technical problems
  • Actively participate in group and project teamwork; project and process improvements
  • Resolve issues as needed with management approval
  • Adhere to cGMP policies and procedures, including documentation activities
Responsibilities
  • Review routine and non-routine records / documents, ensuring records support good-documentation-practices and demonstrate cGMP
  • Partner with manufacturing and technical resources to ensure records are complete and product quality impact rationale is complete to support batch disposition decision(s)
  • Partner with manufacturing and technical resources to troubleshoot and address any equipment issues with production promptly to minimize downtime
  • Routinely walk-through manufacturing and warehouse areas to confirm operations and the areas support cGMP operations
  • Receive and provide coaching and training to personnel in the organization
  • Perform a broad variety of basic and moderate complex tests in support of quality assurance activities as required
  • Perform other duties as requested by supervisor/manager to support Quality operations
  • Escalation of significant issues to organizational leaders as required
  • Collaborate with cross-functional teams, including manufacturing, quality control, and quality assurance, to address environmental monitoring-related issues and implement corrective actions

Orca Bio operates in the biotechnology field, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to significantly impact healthcare by advancing cell therapy treatments for conditions that currently have limited options.

Company Stage

Series D

Total Funding

$375M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

15%

1 year growth

19%

2 year growth

39%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.

Help us improve and share your feedback! Did you find this helpful?